German Brüstle Decision Puts Spotlight on National Patent Guidelines
By Julian Hitchcock,
BioNews
| 12. 17. 2012
Untitled Document
On 27 November the case of Brüstle v Greenpeace was remitted to the German Federal High Court. Its decision had been awaited impatiently. How exactly would a national court interpret the controversial ruling of the Court of Justice of the European Union (CJEU), which in October 2011, had held that patent rights could not be granted in the EU for the use of any entity 'capable of commencing the process of development of a human being'?
Dubbed 'human embryos' for purposes of the Biotechnology Directive (Directive 98/44), fertilised eggs, CNR (cell nucleus replacement) eggs, parthenotes and anything else having the capacity to begin the journey of human development, could not, the CJEU declared, be patented for 'industrial or commercial purposes' (a term which it also construed broadly). All that mattered, said the CJEU, was the potential to begin development. The fact that such entities cannot complete their development (technical and legal limitations prevent them from even developing bodies) was immaterial.
Read more...
Related Articles
By Jan Grue, The Guardian | 10.27.2026
For a very long time, I dreamed of being cured. I was born in 1981. I learned to walk early enough, but I stumbled and fell more easily than other children. My parents began to worry that something was wrong...
By staff, We Are Egg Donors | 10.21.2026
Michelle Lambrechts is a police officer and one-time egg donor in Belgium. She is also the founder of Ik Zit Met Een Ei, a Belgian nonprofit that advocates for egg donors. (The name is a Dutch play on words...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...